CS Medica AS (XSAT:CSMED) YoY EBITDA Growth : 60.18% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is CS Medica AS YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. CS Medica AS's YoY EBITDA Growth for the quarter that ended in Sep. 2024 was 60.18%.

CS Medica AS's EBITDA per Share for the three months ended in Sep. 2024 was kr-0.13.

CS Medica AS YoY EBITDA Growth Historical Data

The historical data trend for CS Medica AS's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CS Medica AS YoY EBITDA Growth Chart

CS Medica AS Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

YoY EBITDA Growth

Get a 7-Day Free Trial

115.79

434.15

-541.10

-32.61

50.66

CS Medica AS Quarterly Data
	Sep19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
YoY EBITDA Growth	Get a 7-Day Free Trial														-978.95	3.19	53.82	25.30	60.18

CS Medica AS YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

CS Medica AS's YoY EBITDA Growth for the fiscal year that ended in Sep. 2024 is calculated as:

	YoY EBITDA Growth (A: Sep. 2024 )
=	(EBITDA per Share (A: Sep. 2024 )	-	EBITDA per Share (A: Sep. 2023 ))	/	\| EBITDA per Share (A: Sep. 2023 ) \|
=	(-0.632	-	-1.281)	/	\| -1.281 \|
=	50.66 %

CS Medica AS's YoY EBITDA Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY EBITDA Growth (Q: Sep. 2024 )
=	(EBITDA per Share (Q: Sep. 2024 )	-	EBITDA per Share (Q: Sep. 2023 ))	/	\| EBITDA per Share (Q: Sep. 2023 )) \|
=	(-0.133	-	-0.334)	/	\| -0.334 \|
=	60.18 %

CS Medica AS YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of CS Medica AS's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

CS Medica AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CS Medica AS (XSAT:CSMED) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Indiakaj 10, Copenhagen, DNK, 2100

Website

https://www.cs-medica.com

CS Medica AS is engaged in developing, manufacturing, and commercializing over-the-counter medical device products containing cannabinoids currently focusing on cannabidiol for the treatment of psoriasis and arthritis. It operates in two business segments such as GalaxaPharma A/S responsible for distribution operation for marketing and sales direct-to-consumer, to retailers, and e-tail and CANNORDIC A/S is engaged in research and development, establishing of global business contracts, supply of CBD ingredients and production of finished products.

CS Medica AS Headlines

No Headlines